Nursing dwelling COVID deaths have fallen 75% since December as new instances have decreased by 90%.

One of many earliest bother spots for coronavirus pandemics is a speedy decline in instances and deaths that far surpasses the US: nursing houses.[outpaces[theUS:nursinghomes[outpaces[theUS:nursinghomes

Between late December and mid-February, weekly infections among residents decreased by almost 90 percent – twice as common as in the general population. This comes from a DailyMail.com analysis of the federal data.

As deaths increased in the US during the winter holidays, deaths in nursing homes decreased by up to 75 percent.

Experts say COVID-19 vaccinations, introduced in December and giving priority to nursing home residents, played a big role in the dramatic drop

Some say the data shows that not only are the vaccines effective, but the country appears to see massive improvements as more people are vaccinated.

By comparison, national cases fell from a weekly total of 1,507,588 to 657,032 over the same period, a decrease of 58%

Since the earliest days of the pandemic, those living in nursing homes and assisted living facilities have been among the most vulnerable populations.

Seniors in these centers lived in confined spaces with multiple risk factors such as age and chronic conditions such as high blood pressure and diabetes.

In addition, the immune system weakens with age, making it difficult for the body of older patients to fight off viruses and other pathogens at all.

This not only puts them at a higher risk of complications, but also of hospitalizations and death.

Some of the earliest deaths from COVID-19 occurred at the Life Care Center, a care facility in Kirkland, Washington.

Between February 19 and March 10, 26 of the nursing home’s 120 patients died, with at least 13 autopsies confirming the coronavirus was the cause.

Between late December and mid-February, weekly deaths in nursing homes decreased 75% from 6,042 to 1,464

By comparison, deaths in the U.S. rose between late December and early February before finally declining

Since then, the virus has reached at least 31,000 long-term care facilities nationwide, infected more than 1.1 million residents and employees, and killed more than 129,000 people.

Long-term care facility residents make up less than one percent of the U.S. population, but 43 percent of all COVID-19 deaths through June, according to AARP.

That trend changed, however, after both Pfizer-BioNTech’s and Moderna vaccines were approved by the U.S. Food and Drug Administration in December.

Nursing home residents and staff were among the highest priority groups and therefore were among the first to be vaccinated.

The effects were seen back in January, with both cases and death falling rapidly, much faster than on a national scale.

Between December 20 and February 14, weekly infections among residents fell from 33,621 to 3,505, which is almost 90 percent.

Experts say the boom is likely due to the distribution of vaccines in the vaccine, with at least three-quarters of residents receiving a dose. Pictured: CVS pharmacist Gerard Diebner delivers the COVID-19 vaccine to a nursing home at the Harlem Center for Nursing and Rehabilitation, a nursing home facility in Harlem, on Jan.

By comparison, national cases fell from 1,507,588 to 657,032 over the same period, a decrease of 58 percent.

This means the number of cases in nursing homes has been almost double that of the general population and is currently the lowest since May when the federal government started tracking infections.

In the case of deaths, weekly deaths fell 75 percent from 6,042 on December 20 to 1,464 on February 14, although the death toll rose to record levels nationwide

Experts say the boom is likely due to the distribution of vaccines in the vaccine, with at least 75 percent receiving a dose, according to the Centers for Disease Control and Prevention.

“I’m almost speechless about how amazing it is and how exciting,” said Dr. David Gifford, chief medical officer of the American Health Care Association, told the New York Times.

“If we see a robust response with this vaccine in the elderly with a highly contagious disease, I think that is a great sign for the rest of the population.”